Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
OMX Stockholm Small Cap PI | OMXSSCPI | Nov 22, 2024 | 1 049.70 | +0.67 |
OMX Stockholm Technology PI | SX10PI | Nov 22, 2024 | 1 655.45 | +0.82 |
OMX Stockholm Telecommunications PI | SX15PI | Nov 22, 2024 | 849.77 | +1.16 |
OMX Stockholm Travel & Leisure PI | SX4050PI | Nov 22, 2024 | 7 316.35 | +0.73 |
OMX Stockholm Utilities PI | SX65PI | Nov 22, 2024 | 469.18 | +1.28 |
OMXS SC 30 ESG Responsible GI | OMXSS30ESGGI | Nov 22, 2024 | 871.89 | +1.72 |
Oncopeptides | ONCO | Nov 22, 2024 | 1.54 | +1.72 |
OncoZenge | ONCOZ | Nov 22, 2024 | 3.50 | -13.49 |
Oneflow | ONEF | Nov 22, 2024 | 36.80 | +2.22 |
Online Brands Nordic | OBAB | Nov 22, 2024 | 10.55 | -2.77 |
oodash Group | OODA | Nov 22, 2024 | 35.00 | +7.03 |
Opter | OPTER | Nov 22, 2024 | 118.50 | +0.42 |
OptiCept Technologies | OPTI | Nov 22, 2024 | 5.07 | +1.40 |
Orexo | ORX | Nov 22, 2024 | 9.55 | +1.60 |
OrganoClick | ORGC | Nov 22, 2024 | 2.66 | +2.31 |
Orron Energy AB | ORRON | Nov 22, 2024 | 6.71 | +1.76 |
Ortivus A | ORTIA | Nov 22, 2024 | 2.86 | -0.69 |
Ortivus B | ORTIB | Nov 22, 2024 | 1.80 | 0.00 |
Ortoma B | ORTB | Nov 22, 2024 | 11.30 | +2.73 |
OssDsign | OSSD | Nov 22, 2024 | 8.05 | +1.26 |
OurLiving AB | OURLIV | Nov 22, 2024 | 0.20 | 0.00 |
Ovzon | OVZON | Nov 22, 2024 | 15.36 | -1.16 |
OXE Marine | OXE | Nov 22, 2024 | 0.37 | +3.06 |
Pandox B | PNDXB | Nov 22, 2024 | 183.80 | +3.26 |
Paradox Interactive | PDX | Nov 22, 2024 | 182.50 | -0.65 |
Paxman | PAX | Nov 22, 2024 | 67.80 | +7.62 |
Peab B | PEABB | Nov 22, 2024 | 81.10 | +0.68 |
Peptonic Medical | PMED | Nov 22, 2024 | 0.00 | 0.00 |
Perpetua Medical B | PERPB | Nov 22, 2024 | 4.88 | -6.15 |
PetroNor E&P ASA | PNORO | Nov 22, 2024 | 10.40 | -1.33 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.